2,3-epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation

F. L. Chung, H. J C Chen, Joseph Guttenplan, A. Nishikawa, G. C. Hard

Research output: Contribution to journalArticle

Abstract

Trans-4-hydroxy-2-nonenal (HNE) is a product of lipid peroxidation. In the presence of t-butyl hydroperoxide the racemic HNE readily converts to its epoxide, 2,3-epoxy-4-hydroxynonanal (EH), as a pair of diastereomers. In this study, the potential roles of HNE and EH as tumor initiating agents were assessed. The mutagenicities of HNE and EH isomers in Salmonella strains TA100 and 104 were examined. In addition, the tumor initiating activities of HNE and EH were evaluated in bioassays involving either topical application in CD-1 mice or i.p. administration in newborn CD-1 mice. In the mutagenicity assays, EH isomers induced similar levels of revenants in both tester strains, although EG isomers were previously shown to react with bases in DNA with different specificity (Sodum, R.S. and Chung, F.-L., Cancer Res., 51, 137-143, 1991). The major isomer induced ∼20 000 revertants/μmol in TA100 and 15 000 revertants/μmol in TA104, whereas, the minor isomer induced ∼40 000 revertants/μmol in TA100 and 20 000 revertants/μmol in TA104. HNE was, however, not mutagenic under the assay conditions. In the tumor bioassays, EH was a weak tumorigen in CD-1 mice upon topical application followed by TPA promotion, yielding 0.55 tumors/mouse and 40% tumor incidence at a total dose of 128 μmol/mouse versus 0.02 tumors/mouse and 5% tumor incidence in the control group. Both HNE and EH induced liver tumors in male mice, but not in female mice. However, the incidences were not statistically significant. EH administered i.p. at a total dose of 200 nmol/mouse exacerbated the chronic spontaneous nephropathy in newborn CD-1 mice. Although the incidence of mild nephropathy was comparable in both EH-treated and control groups, the incidence of more severe lesions in mice treated with 200 nmol/mouse was 21%; while it was 0% in the control group. Furthermore, two mice at each dose level of EH showed a tubule profile with complex hyperplastic lining, suggestive of atypical hyperplasia. Again, HNE was not as active as EH in these bioassays. These results suggest a possible role of EH in tumorigenesis associated with lipid peroxidation.

Original languageEnglish (US)
Pages (from-to)2073-2077
Number of pages5
JournalCarcinogenesis
Volume14
Issue number10
StatePublished - Oct 1993

Fingerprint

Lipid Peroxidation
Epoxy
Lipids
Mouse
Tumors
Tumor
Isomers
Bioassay
Neoplasms
Incidence
Biological Assay
Assays
Dose
Salmonella
2,3-epoxy-4-hydroxynonanal
Lipid peroxidation
Control Groups
Linings
Liver
tert-Butylhydroperoxide

ASJC Scopus subject areas

  • Cancer Research
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Behavioral Neuroscience

Cite this

Chung, F. L., Chen, H. J. C., Guttenplan, J., Nishikawa, A., & Hard, G. C. (1993). 2,3-epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation. Carcinogenesis, 14(10), 2073-2077.

2,3-epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation. / Chung, F. L.; Chen, H. J C; Guttenplan, Joseph; Nishikawa, A.; Hard, G. C.

In: Carcinogenesis, Vol. 14, No. 10, 10.1993, p. 2073-2077.

Research output: Contribution to journalArticle

Chung, FL, Chen, HJC, Guttenplan, J, Nishikawa, A & Hard, GC 1993, '2,3-epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation', Carcinogenesis, vol. 14, no. 10, pp. 2073-2077.
Chung, F. L. ; Chen, H. J C ; Guttenplan, Joseph ; Nishikawa, A. ; Hard, G. C. / 2,3-epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation. In: Carcinogenesis. 1993 ; Vol. 14, No. 10. pp. 2073-2077.
@article{7721facb987745aa87464f426e4f7a31,
title = "2,3-epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation",
abstract = "Trans-4-hydroxy-2-nonenal (HNE) is a product of lipid peroxidation. In the presence of t-butyl hydroperoxide the racemic HNE readily converts to its epoxide, 2,3-epoxy-4-hydroxynonanal (EH), as a pair of diastereomers. In this study, the potential roles of HNE and EH as tumor initiating agents were assessed. The mutagenicities of HNE and EH isomers in Salmonella strains TA100 and 104 were examined. In addition, the tumor initiating activities of HNE and EH were evaluated in bioassays involving either topical application in CD-1 mice or i.p. administration in newborn CD-1 mice. In the mutagenicity assays, EH isomers induced similar levels of revenants in both tester strains, although EG isomers were previously shown to react with bases in DNA with different specificity (Sodum, R.S. and Chung, F.-L., Cancer Res., 51, 137-143, 1991). The major isomer induced ∼20 000 revertants/μmol in TA100 and 15 000 revertants/μmol in TA104, whereas, the minor isomer induced ∼40 000 revertants/μmol in TA100 and 20 000 revertants/μmol in TA104. HNE was, however, not mutagenic under the assay conditions. In the tumor bioassays, EH was a weak tumorigen in CD-1 mice upon topical application followed by TPA promotion, yielding 0.55 tumors/mouse and 40{\%} tumor incidence at a total dose of 128 μmol/mouse versus 0.02 tumors/mouse and 5{\%} tumor incidence in the control group. Both HNE and EH induced liver tumors in male mice, but not in female mice. However, the incidences were not statistically significant. EH administered i.p. at a total dose of 200 nmol/mouse exacerbated the chronic spontaneous nephropathy in newborn CD-1 mice. Although the incidence of mild nephropathy was comparable in both EH-treated and control groups, the incidence of more severe lesions in mice treated with 200 nmol/mouse was 21{\%}; while it was 0{\%} in the control group. Furthermore, two mice at each dose level of EH showed a tubule profile with complex hyperplastic lining, suggestive of atypical hyperplasia. Again, HNE was not as active as EH in these bioassays. These results suggest a possible role of EH in tumorigenesis associated with lipid peroxidation.",
author = "Chung, {F. L.} and Chen, {H. J C} and Joseph Guttenplan and A. Nishikawa and Hard, {G. C.}",
year = "1993",
month = "10",
language = "English (US)",
volume = "14",
pages = "2073--2077",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - 2,3-epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation

AU - Chung, F. L.

AU - Chen, H. J C

AU - Guttenplan, Joseph

AU - Nishikawa, A.

AU - Hard, G. C.

PY - 1993/10

Y1 - 1993/10

N2 - Trans-4-hydroxy-2-nonenal (HNE) is a product of lipid peroxidation. In the presence of t-butyl hydroperoxide the racemic HNE readily converts to its epoxide, 2,3-epoxy-4-hydroxynonanal (EH), as a pair of diastereomers. In this study, the potential roles of HNE and EH as tumor initiating agents were assessed. The mutagenicities of HNE and EH isomers in Salmonella strains TA100 and 104 were examined. In addition, the tumor initiating activities of HNE and EH were evaluated in bioassays involving either topical application in CD-1 mice or i.p. administration in newborn CD-1 mice. In the mutagenicity assays, EH isomers induced similar levels of revenants in both tester strains, although EG isomers were previously shown to react with bases in DNA with different specificity (Sodum, R.S. and Chung, F.-L., Cancer Res., 51, 137-143, 1991). The major isomer induced ∼20 000 revertants/μmol in TA100 and 15 000 revertants/μmol in TA104, whereas, the minor isomer induced ∼40 000 revertants/μmol in TA100 and 20 000 revertants/μmol in TA104. HNE was, however, not mutagenic under the assay conditions. In the tumor bioassays, EH was a weak tumorigen in CD-1 mice upon topical application followed by TPA promotion, yielding 0.55 tumors/mouse and 40% tumor incidence at a total dose of 128 μmol/mouse versus 0.02 tumors/mouse and 5% tumor incidence in the control group. Both HNE and EH induced liver tumors in male mice, but not in female mice. However, the incidences were not statistically significant. EH administered i.p. at a total dose of 200 nmol/mouse exacerbated the chronic spontaneous nephropathy in newborn CD-1 mice. Although the incidence of mild nephropathy was comparable in both EH-treated and control groups, the incidence of more severe lesions in mice treated with 200 nmol/mouse was 21%; while it was 0% in the control group. Furthermore, two mice at each dose level of EH showed a tubule profile with complex hyperplastic lining, suggestive of atypical hyperplasia. Again, HNE was not as active as EH in these bioassays. These results suggest a possible role of EH in tumorigenesis associated with lipid peroxidation.

AB - Trans-4-hydroxy-2-nonenal (HNE) is a product of lipid peroxidation. In the presence of t-butyl hydroperoxide the racemic HNE readily converts to its epoxide, 2,3-epoxy-4-hydroxynonanal (EH), as a pair of diastereomers. In this study, the potential roles of HNE and EH as tumor initiating agents were assessed. The mutagenicities of HNE and EH isomers in Salmonella strains TA100 and 104 were examined. In addition, the tumor initiating activities of HNE and EH were evaluated in bioassays involving either topical application in CD-1 mice or i.p. administration in newborn CD-1 mice. In the mutagenicity assays, EH isomers induced similar levels of revenants in both tester strains, although EG isomers were previously shown to react with bases in DNA with different specificity (Sodum, R.S. and Chung, F.-L., Cancer Res., 51, 137-143, 1991). The major isomer induced ∼20 000 revertants/μmol in TA100 and 15 000 revertants/μmol in TA104, whereas, the minor isomer induced ∼40 000 revertants/μmol in TA100 and 20 000 revertants/μmol in TA104. HNE was, however, not mutagenic under the assay conditions. In the tumor bioassays, EH was a weak tumorigen in CD-1 mice upon topical application followed by TPA promotion, yielding 0.55 tumors/mouse and 40% tumor incidence at a total dose of 128 μmol/mouse versus 0.02 tumors/mouse and 5% tumor incidence in the control group. Both HNE and EH induced liver tumors in male mice, but not in female mice. However, the incidences were not statistically significant. EH administered i.p. at a total dose of 200 nmol/mouse exacerbated the chronic spontaneous nephropathy in newborn CD-1 mice. Although the incidence of mild nephropathy was comparable in both EH-treated and control groups, the incidence of more severe lesions in mice treated with 200 nmol/mouse was 21%; while it was 0% in the control group. Furthermore, two mice at each dose level of EH showed a tubule profile with complex hyperplastic lining, suggestive of atypical hyperplasia. Again, HNE was not as active as EH in these bioassays. These results suggest a possible role of EH in tumorigenesis associated with lipid peroxidation.

UR - http://www.scopus.com/inward/record.url?scp=0027365095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027365095&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 2073

EP - 2077

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 10

ER -